Confibay
← All signals on September 8, 2026
Archive

INBX

SELL
September 8, 2026Horizon stated in the case: 5 trading days

Published once at least 12 trading days had closed after this run.

Summary

Sell INBX into strength. Exit/reduce longs at 114.34 INBX with bounce sales toward 118.37 (10-EMA) resistance; do not chase. Position size zero to minimal given ATR 8.68, IV 111.6%, beta 3.67. Risk levels: invalidation above 120.18-121.17; downside targets 104.94 then 50-day 97.58; hard exit on VWMA 113.84 break. Horizon 5 trading days.

The case

INBX closed 114.34 after 120.18-94.00 intraday crash on 1.67M shares (8.6x volume), closing below 10-EMA 118.37 and only +0.50 above VWMA 113.84. MACD histogram collapsed 3.44 to 0.19 (-94%), RSI cooled 75 to 56.7, ATR +19.6% to 8.68. Our analysis sees Sell: thin VWMA hold is exhaustion/distribution, not absorption; resistance stack 118.37/120.18/121.17 overhead; put/call volume 4.03, IV 111.6% defensive. Fundamentals override interim 48% ORR Phase 2 INBRX-106+pembro (+6% pop, CEO 25k @105.82): zero revenue, -53M equity, 181.6M debt, 133.3M cash burning ~30M/qtr = 4.4Q runway, working capital 144.8M to 114.1M, net debt 13.3M to 42.9M, interest +62% to 5.69M, SG&A 5.71M to 8.25M, 10-Q warns interim may not hold, trial expansion extends burn/delays final. A partial trim approach is rejected: 17% cushion to 50-SMA 97.58 is air, a market fear gauge at 40.6 + beta 3.67 fragility demands capital preservation over optionality. No prior INBX history to contradict.

What would weaken it

  • Break and hold above 120.18-121.17 invalidates bear thesis
  • Interim 48% ORR validates and trial momentum reignites
  • Elevated IV 111.6% and beta 3.67 fuel sharp squeeze

This case is at least 12 trading days old. The current day’s signals are for members.